Literature DB >> 31296155

Inflammation as the Common Biological Link Between Depression and Cardiovascular Diseases: Can Carnosine Exert a Protective Role?

Giuseppe Caruso1, Claudia G Fresta2, Margherita Grasso1,3, Rosa Santangelo3, Giuseppe Lazzarino4, Susan M Lunte5,6,7, Filippo Caraci1,3.   

Abstract

Several epidemiological studies have clearly shown the high co-morbidity between depression and Cardiovascular Diseases (CVD). Different studies have been conducted to identify the common pathophysiological events of these diseases such as the overactivation of the hypothalamic- pituitary-adrenal axis and, most importantly, the dysregulation of immune system which causes a chronic pro-inflammatory status. The biological link between depression, inflammation, and CVD can be related to high levels of pro-inflammatory cytokines, such as IL-1β, TNF-α, and IL-6, released by macrophages which play a central role in the pathophysiology of both depression and CVD. Pro-inflammatory cytokines interfere with many of the pathophysiological mechanisms relevant to depression by upregulating the rate-limiting enzymes in the metabolic pathway of tryptophan and altering serotonin metabolism. These cytokines also increase the risk to develop CVD, because activation of macrophages under this pro-inflammatory status is closely associated with endothelial dysfunction and oxidative stress, a preamble to atherosclerosis and atherothrombosis. Carnosine (β-alanyl-L-histidine) is an endogenous dipeptide which exerts a strong antiinflammatory activity on macrophages by suppressing reactive species and pro-inflammatory cytokines production and altering pro-inflammatory/anti-inflammatory macrophage polarization. This dipeptide exhibits antioxidant properties scavenging reactive species and preventing oxidative stress-induced pathologies such as CVD. In the present review we will discuss the role of oxidative stress and chronic inflammation as common pathophysiological events both in depression and CVD and the preclinical and clinical evidence on the protective effect of carnosine in both diseases as well as the therapeutic potential of this dipeptide in depressed patients with a high co-morbidity of cardiovascular diseases. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Carnosine; cardiovascular diseases; depression; inflammation; macrophages; oxidative stress.

Mesh:

Substances:

Year:  2020        PMID: 31296155     DOI: 10.2174/0929867326666190712091515

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  18 in total

Review 1.  Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders.

Authors:  Anna Morozova; Yana Zorkina; Olga Abramova; Olga Pavlova; Konstantin Pavlov; Kristina Soloveva; Maria Volkova; Polina Alekseeva; Alisa Andryshchenko; Georgiy Kostyuk; Olga Gurina; Vladimir Chekhonin
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

2.  Cecal Metabolomic Fingerprint of Unscathed Rats: Does It Reflect the Good Response to a Provocative Decompression?

Authors:  Anne-Virginie Desruelle; Sébastien de Maistre; Sandrine Gaillard; Simone Richard; Catherine Tardivel; Jean-Charles Martin; Jean-Eric Blatteau; Alain Boussuges; Sarah Rives; Jean-Jacques Risso; Nicolas Vallee
Journal:  Front Physiol       Date:  2022-05-17       Impact factor: 4.755

3.  Dietary Phytoestrogen Intake and Cognitive Status in Southern Italian Older Adults.

Authors:  Francesca Giampieri; Justyna Godos; Giuseppe Caruso; Marcin Owczarek; Joanna Jurek; Sabrina Castellano; Raffaele Ferri; Filippo Caraci; Giuseppe Grosso
Journal:  Biomolecules       Date:  2022-05-30

4.  Fluoxetine Ecofriendly Nanoemulsion Enhances Wound Healing in Diabetic Rats: In Vivo Efficacy Assessment.

Authors:  Nabil A Alhakamy; Giuseppe Caruso; Anna Privitera; Osama A A Ahmed; Usama A Fahmy; Shadab Md; Gamal A Mohamed; Sabrin R M Ibrahim; Basma G Eid; Ashraf B Abdel-Naim; Filippo Caraci
Journal:  Pharmaceutics       Date:  2022-05-26       Impact factor: 6.525

Review 5.  Antidepressant Drugs and Physical Activity: A Possible Synergism in the Treatment of Major Depression?

Authors:  Claudia Savia Guerrera; Giovanna Furneri; Margherita Grasso; Giuseppe Caruso; Sabrina Castellano; Filippo Drago; Santo Di Nuovo; Filippo Caraci
Journal:  Front Psychol       Date:  2020-05-06

6.  Different Modulatory Effects of Four Methicillin-Resistant Staphylococcus aureus Clones on MG-63 Osteoblast-Like Cells.

Authors:  Nicolò Musso; Giuseppe Caruso; Dafne Bongiorno; Margherita Grasso; Dalida A Bivona; Floriana Campanile; Filippo Caraci; Stefania Stefani
Journal:  Biomolecules       Date:  2021-01-07

7.  Nutritional Psychiatry: How Diet Affects Brain through Gut Microbiota.

Authors:  Giuseppe Grosso
Journal:  Nutrients       Date:  2021-04-14       Impact factor: 5.717

Review 8.  The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment.

Authors:  Anna Giménez-Palomo; Seetal Dodd; Gerard Anmella; Andre F Carvalho; Giselli Scaini; Joao Quevedo; Isabella Pacchiarotti; Eduard Vieta; Michael Berk
Journal:  Front Psychiatry       Date:  2021-07-06       Impact factor: 4.157

Review 9.  Novel Insight into Neuroimmune Regulatory Mechanisms and Biomarkers Linking Major Depression and Vascular Diseases: The Dilemma Continues.

Authors:  Ingrid Tonhajzerova; Nikola Sekaninova; Lucia Bona Olexova; Zuzana Visnovcova
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

10.  The Therapeutic Potential of Carnosine/Anserine Supplementation against Cognitive Decline: A Systematic Review with Meta-Analysis.

Authors:  Giuseppe Caruso; Justyna Godos; Sabrina Castellano; Agnieszka Micek; Paolo Murabito; Fabio Galvano; Raffaele Ferri; Giuseppe Grosso; Filippo Caraci
Journal:  Biomedicines       Date:  2021-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.